Physician

Reed Evans Cope, MD

According to 2025 Medicare claims, Reed Cope, MD (NPI: 1801214267) practices radiation oncology in the Columbia, MO market, with the plurality of this provider's patient population coming from Boone, MO. This provider's primary affiliated billing organization is MISSOURI CANCER ASSOCIATES LLC (NPI: 1215947338; TIN: 431763016) and primary practice location at 65201-7167. Cope is affiliated with the Aledade 93 National MSSP Enhanced (ACO ID: A5206), participating under the MSSP model.

Cope's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 534 traditional Medicare patients, billed 3,635 HCPCS/CPT codes, and received $481,388 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 213 prescription claims across 100 beneficiaries totaling $2,086 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 142 records totaling $13,815. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $8,822 to $2,086. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$317K$633K2019 Medicare payment: $108,459 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $374,043 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $342,065 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $633,444 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $591,352 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $481,388 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191722,124$108,459
20205314,567$374,043
20215096,937$342,065
202259711,212$633,444
20235094,271$591,352
20245343,635$481,388

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.4K$8.8K2015 Drug cost: $8,822 (USD; Tot_Drug_Cst)2019 Drug cost: $389 (USD; Tot_Drug_Cst)2020 Drug cost: $1,901 (USD; Tot_Drug_Cst)2021 Drug cost: $3,457 (USD; Tot_Drug_Cst)2022 Drug cost: $3,291 (USD; Tot_Drug_Cst)2023 Drug cost: $3,603 (USD; Tot_Drug_Cst)2024 Drug cost: $2,086 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152393$8,822
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191315$389
20205193$1,901
202176132$3,457
202283145$3,291
202368148$3,603
2024100213$2,086

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77427Radiation treatment management, 5 treatment sessions127260$140
77334Design and construction of complex radiation treatment device109262$76
77014Ct guidance for insertion of radiation therapy fields195829$63
77336Continuing radiation therapy consultation per week133250$61
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more126145$49

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tamsulosin HclTamsulosin Hcl823,525$647
Memantine HclMemantine Hcl12429$173
Oxycodone HclOxycodone Hcl1176$166
Levothyroxine SodiumLevothyroxine Sodium18687$121

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.129$2,733Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.13$11,083Sumitomo Pharma America, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Reed Evans Cope, MD?

Tedicare shows public-source Medicare data for Reed Evans Cope, MD (NPI 1801214267), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Reed Evans Cope, MD have ACO affiliation data?

Reed Evans Cope, MD is shown with ACO affiliation data for Aledade 93 National MSSP Enhanced (MSSP, ACO ID A5206).

What billing organization is linked to Reed Evans Cope, MD?

Reed Evans Cope, MD is linked to MISSOURI CANCER ASSOCIATES LLC (billing NPI 1215947338) in the available physician profile data.

Does Reed Evans Cope, MD have Open Payments data?

Reed Evans Cope, MD has 142 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.